HealthDay operates under the strictest editorial standards. Our syndicated news content is completely independent of any financial interests, is based solely on industry-respected sources and the latest scientific research, and is carefully fact-checked by a team of industry experts to ensure accuracy.
- All articles are edited and checked for factual accuracy by our Editorial Team prior to being published.
- Unless otherwise noted, all articles focusing on new research are based on studies published in peer-reviewed journals or issued from independent and respected medical associations, academic groups and governmental organizations.
- Each article includes a link or reference to the original source.
- Any known potential conflicts of interest associated with a study or source are made clear to the reader.
Please see our Editorial and Fact-Checking Policy for more detail.Editorial and Fact-Checking Policy
HealthDay Editorial Commitment
HeathDay is committed to maintaining the highest possible levels of impartial editorial standards in the content that we present on our website. All of our articles are chosen independent of any financial interests. Editors and writers make all efforts to clarify any financial ties behind the studies on which we report.
TUESDAY, Jan. 7, 2020 (HealthDay News) -- For couples seeking infertility treatment, folic acid and zinc supplementation compared with placebo for male partners does not significantly improve semen quality or live birth rates, according to a study published in the Jan. 7 issue of the Journal of the American Medical Association.
Enrique F. Schisterman, Ph.D., from the Eunice Kennedy Shriver National Institute of Child Health and Human Development in Bethesda, Maryland, and colleagues conducted a randomized clinical trial involving 2,370 couples planning infertility treatment at four U.S. centers. Men were randomly assigned to receive either 5 mg folic acid and 30 mg elemental zinc or placebo daily (1,185 each) for six months. Sixty-nine percent of the men had semen available for analysis six months after randomization.
The researchers observed no significant difference between the groups in live births (34 percent in the folic acid and zinc group and 35 percent in the placebo group; risk difference, −0.9 percent; 95 percent confidence interval, −4.7 to 2.8 percent). At six months after randomization, there was no significant difference between the groups in most of the semen quality parameters. Compared with placebo, there was a statistically significant increase in DNA fragmentation with folic acid and zinc supplementation (mean, 29.7 versus 27.2 percent; mean difference, 2.4 percent; 95 percent confidence interval, 0.5 to 4.4 percent). Gastrointestinal symptoms occurred more often with folic acid and zinc supplementation than with placebo.
"Our results suggest that these dietary supplements have little to no effect on fertility and may even cause mild gastrointestinal symptoms," Schisterman said in a statement.
One author disclosed financial ties to the pharmaceutical industry, and disclosed having a patent pending for microfluidic sperm sorting.
This story may be outdated. We suggest some alternatives.
The content contained in this article is over two years old. As such our recommendation is that you reference the articles below for the latest updates on this topic. This article has been left on our site as a matter of historic record. Please contact us at firstname.lastname@example.org with any questions.
Updated on May 26, 2022